海外の治験の状況「前立腺癌」での検索結果
242件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- PHASE III STUDY OF CHEMOHORMONAL THERAPY WITH TO DIFFERENT MODALITIES CONCOMITANT OR ALTERNATE VERSUS HORMONAL THERAPY ALONE IN ADVANCED PROSTATE CANCER PATIENTS.
- ADVANCED PROSTATE CANCER br>MedDRA version: 6.1 Level: PT Classification code 10060862
- Italy
- 2007-03-08
Authorised
- VASCULAR-TARGETED PHOTODYNAMIC THERAPY USING WST11 IN PATIENTS WITH LOCALISED PROSTATE CANCER
- Localized prostate cancer br>MedDRA version: 9.1 Level: LLT Classification code 10060862 Term: Prostate cancer
- France, Netherlands, United Kingdom
- 2009-05-28
Authorised
- Chemotherapy with cabazitaxel in advanced prostate cancer
- This study is designed to evaluate the safety of biweekly cabazitaxel for the treatment of metastatic castration resistant prostate cancer (mCRPC) previously treated with docetaxel containing regimen.;Therapeutic area: Diseases [C] - Cancer [C04]
- Finland
- 2011-07-12
Authorised
- Enzalutamide and hypofractionated radiation therapy in intermediate-risk localized prostate cancer
- MedDRA version: 19.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Spain
- 2017-02-28
Authorised
- A phase II study in low risk prostate cancer patients to compare active surveillance with versus without an antiandrogenic treatment.
- Low risk localized prostate cancer br>MedDRA version: 20.0 Level: LLT Classification code 10007113 Term: Cancer of prostate System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- France
- 2017-02-17
Authorised
- A study to evaluate Rucaparib versus physician’s choice of therapy in patients with metastatic castration-resistant prostate cancer
- Metastatic castration-resistant prostate cancer br>MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Spain, United Kingdom, United States
- 2017-02-16
Authorised
- A study investigating if markers for inflammation in the blood in patients with prostate cancer is affected by type of hormonal treatment received.
- Patients with advanced prostate cancer and pre-existing cardiovascular disease MedDRA version: 19.1 Level: LLT Classification code 10036916 Term: Prostate cancer stage D System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Sweden
- 2017-01-13
Authorised
- SAFETY AND PHARMACOKINETICS OF ODM-208 IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
- Metastatic castration-resistant prostate cancer br>MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Finland
- 2017-11-22
Authorised
- An international study of 177LU-PSMA-617 in the treatment of patients with progressive metastatic castration-resistant prostate cancer
- PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, Denmark, France, Germany, Netherlands, Sweden, United Kingdom, United States
- 2018-08-10
Authorised
- An international study of 177LU-PSMA-617 in the treatment of patients with progressive metastatic castration-resistant prostate cancer
- PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, Denmark, France, Germany, Netherlands, Sweden, United Kingdom, United States
- 2018-07-27
